Literature DB >> 25548061

Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation.

S Ben Freedman1, Bernard J Gersh2, Gregory Y H Lip3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25548061     DOI： 10.1093/eurheartj/ehu494

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

1.  Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.

Authors:  Leo M Stolk; Frank de Vries; Chiel Ebbelaar; Anthonius de Boer; Tom Schalekamp; Patrick Souverein; Arina Ten Cate-Hoek; Andrea M Burden
Journal:  Br J Clin Pharmacol       Date:  2017-03-23       Impact factor: 4.335

2.  Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.

Authors:  Tomas Forslund; Björn Wettermark; Paul Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  2015-11-27       Impact factor: 2.953

3.  Anticoagulation in Atrial Fibrillation - Current Concepts.

Authors:  Demosthenes G Katritsis; Bernard J Gersh; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

Review 4.  Atrial fibrillation: the current epidemic.

Authors:  Carlos A Morillo; Amitava Banerjee; Pablo Perel; David Wood; Xavier Jouven
Journal:  J Geriatr Cardiol       Date:  2017-03       Impact factor: 3.327

5.  Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.

Authors:  Carlos Jerjes-Sanchez; Ramon Corbalan; Antonio C P Barretto; Hector L Luciardi; Jagan Allu; Laura Illingworth; Karen S Pieper; Gloria Kayani
Journal:  Clin Cardiol       Date:  2019-04-09       Impact factor: 2.882

6.  Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial.

Authors:  Anne M Holbrook; Kristina Vidug; Lindsay Yoo; Sue Troyan; Sam Schulman; James Douketis; Lehana Thabane; Stephen Giilck; Yousery Koubaesh; Sylvia Hyland; Karim Keshavjee; Joanne Ho; Jean-Eric Tarride; Amna Ahmed; Marianne Talman; Blair Leonard; Khursheed Ahmed; Mohammad Refaei; Deborah M Siegal
Journal:  Pilot Feasibility Stud       Date:  2022-08-02

Review 7.  Treatment of atrial fibrillation: a comprehensive review and practice guide.

Authors:  Jianhua Li; Mei Gao; Minwei Zhang; Donglu Liu; Zhan Li; Juanjuan Du; Yinglong Hou
Journal:  Cardiovasc J Afr       Date:  2020-03-18       Impact factor: 1.167

Review 8.  Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.

Authors:  Fernando J Vazquez; Joaquín P Gonzalez; Esteban Gándara
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

9.  Epidemiology and long-term prognosis of atrial fibrillation in rural African patients.

Authors:  Dakaboué Germain Mandi; Joel Bamouni; Dangwé Temoua Naïbé; Rélwendé Aristide Yaméogo; Elisé Kaboré; Yibar Kambiré; Koudougou Jonas Kologo; Georges Rosario Christian Millogo; Nobila Valentin Yaméogo; Anna Thiam Tall; Patrice Zabsonré
Journal:  Egypt Heart J       Date:  2019-09-05

10.  Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation.

Authors:  Stylianos Tzeis; Paraskevi Savvari; Ioannis Skiadas; Sotirios Patsilinakos; Kimon Stamatelopoulos; Spyridon Kourouklis; Sotirios Kyrikos; Konstantinos Tsatiris; Damianos Menegas; George Hahalis; George Giannakoulas
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.